EUVIMEDEUVIMED entdecken
Open Access

Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database

Ramzi Argoubi iD, Emily S Reese iD, Martina Furegato iD, Patricia Medina, Sarah Bobiak iD

Journal of Comparative Effectiveness Research · 2023-06 · 12 (6)

DOI: 10.57264/cer-2022-0201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2023-06. Verfasst von Ramzi Argoubi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cerner Enviza, Kansas City, MO 64117, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Biliary tract cancers are aggressive, with poor prognosis. This study describes clinical characteristics, treatment patterns and healthcare resource utilization in patients with metastatic biliary tract cancer in Japan. Materials & methods: This cohort-based study collected data from the Japan Medical Data Center claims database (2014–2018).

Results

A total of 325 patients were included; 65.2% were male and the mean age was 59.2 years. A 47.6% had an Elixhauser Comorbidity Index score ≥5. Most frequent regimens were gemcitabine + cisplatin (52.9%) for first-line therapy and tegafur + gimeracil + oteracil for second-line therapy (48.6%) and third-line therapy (27.2%). Approximately 77% of patients had ≥1 hospital admission, with a median length of 57 days.

Conclusion

This study provides insights on the characteristics and burden of metastatic biliary tract cancer in Japan, highlighting high disease burden in a younger population.

Schlagwörter

Stichwörter der Autor:innen

biliary tract cancerbiliary tract carcinomacomparative–effectiveness researcheconomic burdenhealth services researchobservational researchoncologyreal-world evidencetreatment patterns

Autor:innen und Institutionen

  • Cerner Enviza, Kansas City, MO 64117, USA.
  • EMD Serono Research & Development Institute, Inc, Billerica, MA 01821, USA, an affiliate of Merck KGaA.

ORCID-Profile: Ramzi Argoubi, Emily S Reese, Martina Furegato, Sarah Bobiak

Zitieren

APA

Argoubi, R., Reese, E. S., Furegato, M., Medina, P., & Bobiak, S. (2023). Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database. Journal of Comparative Effectiveness Research, 12(6). https://doi.org/10.57264/cer-2022-0201

Vancouver

Argoubi R, Reese ES, Furegato M, Medina P, Bobiak S. Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database. Journal of Comparative Effectiveness Research. 2023;12(6). doi:10.57264/cer-2022-0201

BibTeX
@article{Argoubi2023,
  author = {Argoubi, Ramzi and Reese, Emily S and Furegato, Martina and Medina, Patricia and Bobiak, Sarah},
  title = {Advanced or metastatic biliary tract cancer in Japan: a study using the Japan Medical Data Center payer claims database},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2023},
  volume = {12},
  number = {6},
  doi = {10.57264/cer-2022-0201}
}
Kostenlos starten →